Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Angiogenesis regulated by VEGF and its receptors and its clinical application.

× No keyword cloud information.

3 in total

1. A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial.

Authors: Clemens Giessen; Ludwig Fischer von Weikersthal; Axel Hinke; Sebastian Stintzing; Frank Kullmann; Ursula Vehling-Kaiser; Julia Mayerle; Markus Bangerter; Claudio Denzlinger; Markus Sieber; Christian Teschendorf; Jens Freiberg-Richter; Christoph Schulz; Dominik Paul Modest; Nicolas Moosmann; Philipp Aubele; Volker Heinemann
Journal: BMC Cancer Date: 2011-08-23 Impact factor: 4.430

2. Effect of intravitreal injection of ranibizumab on retinal ganglion cells and microvessels in the early stage of diabetic retinopathy in rats with streptozotocin-induced diabetes.

Authors: Ang Xiao; Qiong Zhou; Yi Shao; Hui-Feng Zhong
Journal: Exp Ther Med Date: 2017-05-05 Impact factor: 2.447

3. Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study.

Authors: Takeshi Nagasaka; Hideyuki Mishima; Akira Sawaki; Mototsugu Shimokawa; Michio Inukai; Katsunori Shinozaki; Hiroaki Tanioka; Junichiro Nasu; Tomohiro Nishina; Shoichi Hazama; Masazumi Okajima; Yoshiyuki Yamaguchi
Journal: BMJ Open Date: 2016-06-02 Impact factor: 2.692

3 in total